"InteractorA","InteractorA_type","Relation","InteractorB","InteractorB_type","DB","DB_type","PMID"
"B-cell acute lymphoblastic leukemia;
 B-cell acute lymphocytic leukemia","Disease","Cyclophosphamide [DR:D00287]
 Methotrexate [DR:D00142]
 Mercaptopurine [DR:D00161]
 Clofarabine [DR:D03546]
 Vincristine sulfate [DR:D02197] (Philadelphia chromosome-negative)
 Teniposide [DR:D02698]
 Doxorubicin hydrochloride [DR:D01275]
 Daunorubicin hydrochloride [DR:D01264]
 Mitoxantrone hydrochloride [DR:D02166]
 Imatinib mesylate [DR:D01441] (Philadelphia chromosome positive)
 Dasatinib [DR:D06414] (Philadelphia chromosome positive)
 Ponatinib hydrochloride [DR:D09951] (T315I positive, Philadelphia chromosome positive)
 Blinatumomab [DR:D09325] (Philadelphia chromosome-negative)
 Inotuzumab ozogamicin [DR:D08933]
 Asparaginase [DR:D02997]
 Pegaspargase [DR:D05387]
 Tisagenlecleucel-T [DR:D11386]
 Enocitabine [DR:D01633]
 Calaspargase pegol [DR:D10096]","ICD-O-3.1: 9811/3 B lymphoblastic leukemia/lymphoma, NOS
 ICD-O-3.1: 9812/3 B lymphoblastic leukemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1
 ICD-O-3.1: 9813/3 B lymphoblastic leukemia/lymphoma with t(v;11q23); MLL rearranged
 ICD-O-3.1: 9814/3 B lymphoblastic leukemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)
 ICD-O-3.1: 9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
 ICD-O-3.1: 9816/3 B lymphoblastic leukemia/lymphoma with hypodiploidy (Hypodiploid ALL)
 ICD-O-3.1: 9817/3 B lymphoblastic leukemia/lymphoma with t(5;14)(q31;q32); IL3-IGH
 ICD-O-3.1: 9818/3 B lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)","Disease","KEGG","Disease-Disease Interaction",25781572
"T-cell acute lymphoblastic leukemia;
 T-cell acute lymphocytic leukemia","Disease","Cyclophosphamide [DR:D00287]
 Methotrexate [DR:D00142]
 Mercaptopurine [DR:D00161]
 Clofarabine [DR:D03546]
 Nelarabine [DR:D05134]
 Vincristine sulfate [DR:D02197] (Philadelphia chromosome-negative)
 Teniposide [DR:D02698]
 Doxorubicin hydrochloride [DR:D01275]
 Daunorubicin hydrochloride [DR:D01264]
 Mitoxantrone hydrochloride [DR:D02166]
 Asparaginase [DR:D02997]
 Pegaspargase [DR:D05387]
 Enocitabine [DR:D01633]
 Calaspargase pegol [DR:D10096]","ICD-O-3.1: 9837/3 T lymphoblastic leukemia/lymphoma","Disease","KEGG","Disease-Disease Interaction",25781572
"Acute myeloid leukemia","Disease","Cyclophosphamide [DR:D00287]
 Thioguanine [DR:D06109]
 Cytarabine [DR:D00168]
 Doxorubicin hydrochloride [DR:D01275]
 Daunorubicin hydrochloride [DR:D01264]
 Idarubicin hydrochloride [DR:D01747]
 Mitoxantrone hydrochloride [DR:D02166]
 Midostaurin [DR:D05029] (FLT3 mutation-positive)
 Gilteritinib fumarate [DR:D10800] (FLT3 mutation-positive)
 Gemtuzumab ozogamicin [DR:D03259] (CD33-positive)
 Glasdegib maleate [DR:D11107]
 Arsenic trioxide [DR:D02106]
 Venetoclax [DR:D10679]
 Enasidenib mesylate [DR:D11044] (IDH2 mutation positive)
 Ivosidenib [DR:D11090] (susceptible IDH1 mutation)
 Daunorubicin and cytarabine [DR:D11390]
 Sargramostim [DR:D05803]
 Enocitabine [DR:D01633]","ICD-O: 9896/3, Tumor type: AML with t(8;21)(q22;q22), (AML1/ETO)
 ICD-O: 9871/3, Tumor type: AML with inv(16)(p13q22) or t(16; 16)(p13, q22), (CBF-beta/MYH11)
 ICD-O: 9866/3, Tumor type: Acute promyelocytic leukaemia (AML with t(15;17)(q22;q12), (PML/RAR-alpha) and variants)
 ICD-O: 9897/3, Tumor type: AML with 11q23 (MLL) abnormalities","Disease","KEGG","Disease-Disease Interaction",10502596
"Chronic myeloid leukemia","Disease","Busulfan [DR:D00248]
 Thioguanine [DR:D06109]
 Cytarabine [DR:D00168]
 Imatinib mesylate [DR:D01441] (Philadelphia chromosome positive)
 Dasatinib [DR:D06414] (Philadelphia chromosome positive)
 Nilotinib hydrochloride hydrate [DR:D06413] (Philadelphia chromosome positive)
 Bosutinib hydrate [DR:D09728] (Philadelphia chromosome positive)
 Ponatinib hydrochloride [DR:D09951] (Philadelphia chromosome positive)
 Hydroxyurea [DR:D00341]
 Omacetaxine mepesuccinate [DR:D08956]
 Sodium phosphate P 32 [DR:D05870]","ICD-O: 9875/3, Tumor type: Chronic myelogenous leukaemia","Disease","KEGG","Disease-Disease Interaction",15719031
"Chronic lymphocytic leukemia","Disease","Cyclophosphamide [DR:D00287]
 Chlorambucil [DR:D00266]
 Bendamustine hydrochloride [DR:D07085]
 Fludarabine phosphate [DR:D01907]
 Ibrutinib [DR:D10223] (chromosome 17p deletion)
 Acalabrutinib [DR:D10893]
 Idelalisib [DR:D10560]
 Duvelisib hydrate [DR:D11658]
 Rituximab [DR:D02994] (CD20-positive)
 Ofatumumab [DR:D09314]
 Obinutuzumab [DR:D09321]
 Venetoclax [DR:D10679] (chromosome 17p deletion)
 Alemtuzumab [DR:D02802]
 Sodium phosphate P 32 [DR:D05870]
 Ibritumomab tiuxetan [DR:D04489]
 Rituximab and hyaluronidase [DR:D11393]","ICD-O: 9823/3, Tumor type: Chronic lymphocytic leukemia","Disease","KEGG","Disease-Disease Interaction",18059180
"Hairy cell leukemia","Disease","Cladribine [DR:D01370]
 Moxetumomab pasudotox [DR:D09932]
 Pentostatin [DR:D00155]
 Interferon alfa-2b [DR:D02745]","ICD-O: 9940/3, Tumor type: Hairy cell leukemia","Disease","KEGG","Disease-Disease Interaction",12670461
"Hodgkin lymphoma","Disease","Cyclophosphamide [DR:D00287]
 Chlorambucil [DR:D00266]
 Carmustine [DR:D00254]
 Lomustine [DR:D00363]
 Dacarbazine [DR:D00288]
 Vinblastine sulfate [DR:D01068]
 Vincristine sulfate [DR:D02197]
 Doxorubicin hydrochloride [DR:D01275]
 Bleomycin sulfate [DR:D02177]
 Procarbazine hydrochloride [DR:D00478]
 Brentuximab vedotin [DR:D09587]
 Nivolumab [DR:D10316]
 Pembrolizumab [DR:D10574]","ICD-O: 9650/3, Tumor type: Classical Hodgkin lymphoma
 ICD-O: 9663/3, Tumor type: Nodular sclerosis classical Hodgkin lymphoma
 ICD-O: 9651/3, Tumor type: Lymphocyte-rich classical Hodgkin lymphoma
 ICD-O: 9652/3, Tumor type: Mixed cellularity classical Hodgkin lymphoma
 ICD-O: 9653/3, Tumor type: Lymphocyte-depleted classical Hodgkin lymphoma","Disease","KEGG","Disease-Disease Interaction",15618006
"Burkitt lymphoma","Disease","Cyclophosphamide [DR:D00287]","ICD-O: 9687/3, Tumor type: Burkitt lymphoma
 Although the carcinogens listed and infection with HIV-1 are risk factors for non-Hodgkin lymphoma in general, the strength of association with different histological tumor types is not well understood.","Disease","KEGG","Disease-Disease Interaction",12191637
"Multiple myeloma","Disease","Cyclophosphamide [DR:D00287]
 Melphalan [DR:D00369]
 Melphalan hydrochloride [DR:D08173]
 Carmustine [DR:D00254]
 Doxorubicin hydrochloride [DR:D01275]
 Elotuzumab [DR:D09337]
 Daratumumab [DR:D10777]
 Isatuximab [DR:D11050]
 Belantamab mafodotin [DR:D11595]
 Bortezomib [DR:D03150]
 Carfilzomib [DR:D08880]
 Ixazomib citrate [DR:D10131]
 Panobinostat lactate [DR:D10019]
 Selinexor [DR:D11222]
 Plerixafor [DR:D08971]
 Thalidomide [DR:D00754]
 Lenalidomide [DR:D04687]
 Pomalidomide [DR:D08976]
 Zoledronic acid [DR:D01968]
 Denosumab [DR:D03684]
 Idecabtagene vicleucel [DR:D11556]
 Melphalan flufenamide hydrochloride [DR:D11870]
 Daratumumab and hyaluronidase [DR:D11967]","ICD-O: 9732/3, Tumor type: Plasma cell myeloma","Disease","KEGG","Disease-Disease Interaction",15031034
"Lymphoplasmacytic lymphoma","Disease","Ibrutinib [DR:D10223]
 Ibritumomab tiuxetan [DR:D04489]","ICD-O: 9671/3, Tumor type: Lymphoplasmacytic lymphoma
 Although the carcinogens listed and infection with HIV-1 are risk factors for non-Hodgkin lymphoma in general, the strength of association with different histological tumor types is not well understood.","Disease","KEGG","Disease-Disease Interaction",19362964
"Polycythemia vera","Disease","Ruxolitinib phosphate [DR:D09960]
 Sodium phosphate P 32 [DR:D05870]","ICD-O: 9950/3, Tumor type: Polycythemia vera","Disease","KEGG","Disease-Disease Interaction",16879013
"Small cell lung cancer","Disease","Methotrexate sodium [DR:D02115]
 Etoposide [DR:D00125]
 Etoposide phosphate [DR:D04107]
 Topotecan hydrochloride [DR:D02168]
 Nivolumab [DR:D10316]
 Pembrolizumab [DR:D10574]
 Durvalumab [DR:D10808]
 Atezolizumab [DR:D10773]
 Lurbinectedin [DR:D11644]
 Trilaciclib dihydrochloride [DR:D11987]","ICD-O: 8041/3, Tumor type: Small cell carcinoma","Disease","KEGG","Disease-Disease Interaction",12741677
"Non-small cell lung cancer","Disease","Methotrexate sodium [DR:D02115]
 Pemetrexed sodium hydrate [DR:D06503]
 Gemcitabine hydrochloride [DR:D01155]
 Vinorelbine tartrate [DR:D01935]
 Paclitaxel [DR:D00491]
 Docetaxel [DR:D07866]
 Docetaxel [DR:D02165]
 Gefitinib [DR:D01977] (EGFR mutation positive)
 Erlotinib hydrochloride [DR:D04023] (EGFR mutation positive)
 Afatinib dimaleate [DR:D09733] (EGFR mutation positive)
 Osimertinib mesylate [DR:D10766] (EGFR mutation positive)
 Dacomitinib [DR:D10514] (EGFR mutation positive)
 Dabrafenib mesylate [DR:D10104] (BRAF mutation positive)
 Crizotinib [DR:D09731] (ALK or ROS1-positive)
 Ceritinib [DR:D10551] (ALK positive)
 Alectinib hydrochloride [DR:D10450] (ALK positive)
 Brigatinib [DR:D10866] (ALK positive)
 Lorlatinib [DR:D11012] (ALK positive)
 Trametinib dimethyl sulfoxide [DR:D10176] (BRAF mutation positive)
 Entrectinib [DR:D10926] (ROS1-positive)
 Capmatinib hydrochloride [DR:D10891] (MET exon 14 skipping positive)
 Tepotinib hydrochloride [DR:D11073] (MET exon 14 skipping)
 Bevacizumab [DR:D06409]
 Nivolumab [DR:D10316]
 Pembrolizumab [DR:D10574] (PD-L1 expressed)
 Ramucirumab [DR:D09371]
 Necitumumab [DR:D10018]
 Durvalumab [DR:D10808]
 Atezolizumab [DR:D10773]
 Cemiplimab [DR:D11108]
 Pralsetinib [DR:D11712] (RET fusion positive)
 Selpercatinib [DR:D11713] (RET fusion positive)
 Amivantamab [DR:D11894] (EGFR exon 20 insertion)
 Sotorasib [DR:D12055] (KRAS G12C-mutated)","ICD-O: 8140/3, Tumor type: Adenocarcinoma
 ICD-O: 8070/3, Tumor type: Squamous cell carcinoma","Disease","KEGG","Disease-Disease Interaction",12741677
"Malignant pleural mesothelioma","Disease","Pemetrexed sodium hydrate [DR:D06503]
 Nivolumab [DR:D10316]","ICD-O: 9050/3, Tumor type: Diffuse malignant mesothelioma
 ICD-O: 9050/3, Tumor type: Localized malignant mesothelioma","Disease","KEGG","Disease-Disease Interaction",16216411
"Esophageal cancer","Disease","Floxuridine [DR:D04197]
 Nivolumab [DR:D10316]
 Pembrolizumab [DR:D10574] (PD-L1 expressed)
 Porfimer sodium [DR:D03327]","ICD-O: 8070/3, Tumor type: Squamous cell carcinoma
 ICD-O: 8140/3, Tumor type: Adenocarcinoma","Disease","KEGG","Disease-Disease Interaction",15622457
"Gastric cancer","Disease","Floxuridine [DR:D04197]
 Trifluridine and tipiracil hydrochloride [DR:D10526]
 Docetaxel [DR:D07866]
 Docetaxel [DR:D02165]
 Doxorubicin hydrochloride [DR:D01275]
 Mitomycin [DR:D00208]
 Trastuzumab [DR:D03257] (HER2 overexpressing)
 Nivolumab [DR:D10316]
 Pembrolizumab [DR:D10574] (PD-L1 expressed)
 Ramucirumab [DR:D09371]","ICD-O: 8140/3, Tumor type: Adenocarcinoma
 ICD-O: 8144/3, Tumor type: intestinal type
 ICD-O: 8145/3, Tumor type: diffuse type","Disease","KEGG","Disease-Disease Interaction",11315254
"Pancreatic cancer","Disease","Gemcitabine hydrochloride [DR:D01155]
 Floxuridine [DR:D04197]
 Paclitaxel [DR:D00491]
 Irinotecan hydrochloride [DR:D01061]
 Mitomycin [DR:D00208]
 Erlotinib hydrochloride [DR:D04023]
 Olaparib [DR:D09730] (BRCA-mutated)","ICD-O: 8500/3, Tumor type: Ductal adenocarcinoma","Disease","KEGG","Disease-Disease Interaction",12459728
"Colorectal cancer","Disease","Capecitabine [DR:D01223]
 Floxuridine [DR:D04197]
 Trifluridine and tipiracil hydrochloride [DR:D10526]
 Irinotecan hydrochloride [DR:D01061]
 Encorafenib [DR:D11053] (BRAF mutation positive)
 Regorafenib hydrate [DR:D10137]
 Oxaliplatin [DR:D01790]
 Cetuximab [DR:D03455] (K-Ras wild type, EGFR-expressing)
 Bevacizumab [DR:D06409]
 Panitumumab [DR:D05350] (KRAS and NRAS wild type)
 Nivolumab [DR:D10316] (MSI-H or dMMR)
 Pembrolizumab [DR:D10574] (MSI-H)
 Ramucirumab [DR:D09371]
 Aflibercept [DR:D09574]
 Leucovorin calcium [DR:D01211]
 Levoleucovorin calcium [DR:D04715]
 Calcium levofolinate hydrate [DR:D11555]
 Sodium levofolinate [DR:D11394]","ICD-O: 8140/3, Tumor type: Adenocarcinoma","Disease","KEGG","Disease-Disease Interaction",15000146
"Renal cell carcinoma","Disease","Medroxyprogesterone acetate [DR:D00951]
 Temsirolimus [DR:D06068]
 Everolimus [DR:D02714]
 Axitinib [DR:D03218]
 Tivozanib hydrochloride [DR:D10190]
 Sunitinib malate [DR:D06402]
 Sorafenib tosylate [DR:D06272]
 Pazopanib hydrochloride [DR:D05380]
 Cabozantinib s-malate [DR:D10095]
 Lenvatinib mesylate [DR:D09920]
 Bevacizumab [DR:D06409]
 Ipilimumab [DR:D04603] (MSI-H or dMMR)
 Nivolumab [DR:D10316]
 Pembrolizumab [DR:D10574]
 Avelumab [DR:D10817]
 Aldesleukin [DR:D00748]","ICD-O: 8310/3, Tumor type: Clear cell carcinoma
 ICD-O: 8260/3, Tumor type: Papillary renal cell carcinoma
 ICD-O: 8317/3, Tumor type: Chromophobe renal cell carcinoma
 ICD-O: 8290/0, Tumor type: Oncocytoma
 ICD-O: 8319/3, Tumor type: Carcinoma of the collecting ducts of Bellini","Disease","KEGG","Disease-Disease Interaction",15122209
"Bladder cancer","Disease","Thiotepa [DR:D00583]
 Doxorubicin hydrochloride [DR:D01275]
 Valrubicin [DR:D02697]
 Mitomycin [DR:D00208]
 Erdafitinib [DR:D10927] (FGFR3 or FGFR2 genetic alterations)
 Cisplatin [DR:D00275]
 Nivolumab [DR:D10316]
 Pembrolizumab [DR:D10574] (PD-L1 expressed)
 Avelumab [DR:D10817]
 Atezolizumab [DR:D10773] (PD-L1 expressed)
 Enfortumab vedotin [DR:D11525]","ICD-O: 8120/3, Tumor type: Infiltrating urothelial carcinoma
 ICD-O: 8120/2, Tumor type: Urothelial carcinoma in situ
 ICD-O: 8130/23, Tumor type: Non-invasive papillary urothelial carcinoma, high grade
 ICD-O: 8130/21, Tumor type: Non-invasive papillary urothelial carcinoma, low grade","Disease","KEGG","Disease-Disease Interaction",16110317
"Testicular cancer","Disease","Ifosfamide [DR:D00343]
 Vinblastine sulfate [DR:D01068]
 Etoposide [DR:D00125]
 Etoposide phosphate [DR:D04107]
 Dactinomycin [DR:D00214]
 Bleomycin sulfate [DR:D02177]
 Cisplatin [DR:D00275]","ICD-O: 9064/2, Tumor type: Intratubular germ cell neoplasia, unclassified
 ICD-O: 9061/3, Tumor type: Seminoma
 ICD-O: 9063/3, Tumor type: Spermatocytic seminoma
 ICD-O: 9100/3, Tumor type: Choriocarcinoma
 ICD-O: 9070/3, Tumor type: Embryonal carcinooma
 ICD-O: 9071/3, Tumor type: Yolk sac tumor
 ICD-O: 9080/3, Tumor type: Teratoma","Disease","KEGG","Disease-Disease Interaction",18042148
"Prostate cancer","Disease","Estradiol valerate [DR:D01413]
 Docetaxel [DR:D07866]
 Docetaxel [DR:D02165]
 Cabazitaxel acetonate [DR:D10452]
 Mitoxantrone hydrochloride [DR:D02166]
 Olaparib [DR:D09730] (HRR gene-mutataed)
 Estramustine phosphate sodium [DR:D02398]
 Estramustine phosphate sodium hydrate [DR:D06397]
 Leuprolide acetate [DR:D00989]
 Goserelin acetate [DR:D00573]
 Triptorelin pamoate [DR:D06248]
 Histrelin acetate [DR:D02116]
 Flutamide [DR:D00586]
 Nilutamide [DR:D00965]
 Bicalutamide [DR:D00961]
 Enzalutamide [DR:D10218]
 Apalutamide [DR:D11040]
 Darolutamide [DR:D11045]
 Degarelix acetate [DR:D09400]
 Abiraterone acetate [DR:D09701]
 Sipuleucel-T [DR:D06644]
 Radium Ra 223 dichloride [DR:D10398]
 Estrogens, esterified [DR:D04071]
 Relugolix [DR:D10888]","ICD-O: 8140/3, Tumor type: Adenocarcinoma (acinar)
 ICD-O: 8148/2, Tumor type: Prostatic intraepithelial neoplasia, glade III (PIN III)","Disease","KEGG","Disease-Disease Interaction",12878745
"Endometrial cancer","Disease","Medroxyprogesterone acetate [DR:D00951]
 Lenvatinib mesylate [DR:D09920]
 Pembrolizumab [DR:D10574] (MSI-H or dMMR)
 Dostarlimab [DR:D11366]","ICD-O: 9380/3, Tumor type: Endometrioid adenocarcinoma
 ICD-O: 8441/3, Tumor type: Serous adenocarcinoma","Disease","KEGG","Disease-Disease Interaction",17028294
"Ovarian cancer","Disease","Cyclophosphamide [DR:D00287]
 Melphalan [DR:D00369]
 Thiotepa [DR:D00583]
 Gemcitabine hydrochloride [DR:D01155]
 Paclitaxel [DR:D00491]
 Topotecan hydrochloride [DR:D02168]
 Doxorubicin hydrochloride [DR:D01275]
 Cisplatin [DR:D00275]
 Carboplatin [DR:D01363]
 Bevacizumab [DR:D06409]
 Olaparib [DR:D09730] (HRD-positive)
 Niraparib tosilate hydrate [DR:D11895]
 Rucaparib camsylate [DR:D10982] (BRCA-mutated)
 Altretamine [DR:D02841]","ICD-O: 8441/3, Tumor type: Adenocarcinoma
 ICD-O: 8480/3, Tumor type: Adenocarcinoma
 ICD-O: 8380/3, Tumor type: Adenocarcinoma, not otherwise specified
 ICD-O: 8310/3, Tumor type: Adenocarcinoma
 ICD-O: 9000/3, Tumor type: Malignant Brenner tumor","Disease","KEGG","Disease-Disease Interaction",15111296
"Choriocarcinoma","Disease","Methotrexate sodium [DR:D02115]
 Vinblastine sulfate [DR:D01068]
 Bleomycin sulfate [DR:D02177]","ICD-O: 9100/3, Tumor type: Choriocarcinoma","Disease","KEGG","Disease-Disease Interaction",17613426
"Vulvar cancer","Disease","Imiquimod [DR:D02500]
 Recombinant adsorbed quadrivalent human papillomavirus virus-like particle vaccine [DR:D10192]","ICD-O: 8070/3, Tumor type: Squamous cell carcinoma","Disease","KEGG","Disease-Disease Interaction",12605639
"Cervical cancer","Disease","Recombinant adsorbed quadrivalent human papillomavirus virus-like particle vaccine [DR:D10192]
 Topotecan hydrochloride [DR:D02168]
 Bevacizumab [DR:D06409]
 Pembrolizumab [DR:D10574] (PD-L1 expressed)","ICD-O: 8070/3, Tumor type: Squamous cell carcinoma, not otherwise specified
 ICD-O: 8140/3, Tumor type: Adenocarcinoma","Disease","KEGG","Disease-Disease Interaction",11486705
"Breast cancer","Disease","Fluoxymesterone [DR:D00327]
 Methyltestosterone [DR:D00408]
 Testosterone enanthate [DR:D00958]
 Cyclophosphamide [DR:D00287]
 Thiotepa [DR:D00583]
 Methotrexate sodium [DR:D02115]
 Gemcitabine hydrochloride [DR:D01155]
 Capecitabine [DR:D01223]
 Vinblastine sulfate [DR:D01068]
 Paclitaxel [DR:D00491]
 Docetaxel [DR:D07866]
 Docetaxel [DR:D02165]
 Doxorubicin hydrochloride [DR:D01275]
 Epirubicin hydrochloride [DR:D02214]
 Ixabepilone [DR:D04645]
 Palbociclib [DR:D10372] (HR positive, HER2 negative)
 Ribociclib succinate [DR:D10979] (HR-positive, HER2-negative)
 Abemaciclib [DR:D10688] (HR positive, HER2 negative)
 Everolimus [DR:D02714] (HR positive, HER2 negative)
 Lapatinib ditosylate [DR:D04024] (HER2 overexpressing)
 Neratinib maleate [DR:D10898] (HER2 positive)
 Tucatinib [DR:D11141] (HER2 positive)
 Alpelisib [DR:D11011] (HR-positive, HER2-negative, PIK3CA-mutated)
 Trastuzumab [DR:D03257] (HER2 overexpressing)
 Pertuzumab [DR:D05446] (HER2 positive)
 Trastuzumab emtansine [DR:D09980] (HER2 positive)
 Pembrolizumab [DR:D10574] (triple-negative, PD-L1 expressed)
 Atezolizumab [DR:D10773] (PD-L1 expressed, HR negative, HER2 negative)
 Trastuzumab deruxtecan [DR:D11529] (HER2 positive)
 Olaparib [DR:D09730] (BRCA-mutated, HER2-negative)
 Talazoparib tosylate [DR:D10733] (BRCA mutated, HER2 negative)
 Eribulin mesylate [DR:D08914]
 Pertuzumab, trastuzumab and hyaluronidase [DR:D11934]
 Goserelin acetate [DR:D00573]
 Tamoxifen citrate [DR:D00966] (ER-positive)
 Toremifene citrate [DR:D00967] (ER-positive)
 Fulvestrant [DR:D01161] (HR positive, HER2 negative)
 Anastrozole [DR:D00960] (HR-positive or HR-unknown)
 Letrozole [DR:D00964] (HR-positive)
 Exemestane [DR:D00963] (ER-positive)
 Estrogens, esterified [DR:D04071]
 Margetuximab [DR:D10446] (HER2 positive)
 Sacituzumab govitecan [DR:D10985] (triple negative)
 Letrozole and ribociclib [DR:D11068] (HR positive, HER2 negative)
 Trastuzumab and hyaluronidase [DR:D11560] (HER2 overexpressing or ER/PR negative)","ICD-O: 8500/3, Tumor type: Invasive ductal carcinoma, not otherwise specified
 ICD-O: 8520/3, Tumor type: Invasive lobular carcinoma","Disease","KEGG","Disease-Disease Interaction",10448115
"Thyroid cancer","Disease","Doxorubicin hydrochloride [DR:D01275]
 Dabrafenib mesylate [DR:D10104] (BRAF mutation positive)
 Trametinib dimethyl sulfoxide [DR:D10176] (BRAF mutation positive)
 Sorafenib tosylate [DR:D06272]
 Lenvatinib mesylate [DR:D09920]
 Sodium iodide I 131 [DR:D02259]
 Thyroid [DR:D06482]
 Pralsetinib [DR:D11712] (RET fusion positive)
 Selpercatinib [DR:D11713] (RET fusion positive)","ICD-O: 8260/3, Tumor type: Papillary carcinoma
 ICD-O: 8330/3, Tumor type: Follicular carcinoma
 ICD-O: 8020/3, Tumor type: Undifferentiated (anaplastic) carcinoma
 ICD-O: 8510/3, Tumor type: Medullary carcinoma, NOS","Disease","KEGG","Disease-Disease Interaction",16557281
"Adrenal carcinoma","Disease","Mitotane [DR:D00420]","ICD-O: 8370/3, Tumor type: Adrenal cortical carcinoma","Disease","KEGG","Disease-Disease Interaction",17934868
"Carcinoid","Disease","Telotristat ethyl [DR:D09974]
 Octreotide acetate [DR:D06495]","ICD-O: 8240/3, Tumor type: Carcinoid (well differentiated endocrine neoplasm)","Disease","KEGG","Disease-Disease Interaction",15887161
"Ewing sarcoma","Disease","Dactinomycin [DR:D00214]","ICD-O: 9260/3, Tumor type: Ewing sarcoma","Disease","KEGG","Disease-Disease Interaction",12560386
"Osteosarcoma","Disease","Leucovorin calcium [DR:D01211]
 Levoleucovorin calcium [DR:D04715]
 Calcium levofolinate hydrate [DR:D11555]
 Sodium levofolinate [DR:D11394]","ICD-O: 9180/3, Tumor type: Osteosarcoma","Disease","KEGG","Disease-Disease Interaction",11378650
"Rhabdomyosarcoma","Disease","Vincristine sulfate [DR:D02197]
 Dactinomycin [DR:D00214]","ICD-O: 8920/3, Tumor type: Alveolar rhabdomyosarcoma","Disease","KEGG","Disease-Disease Interaction",19008039
"Melanoma","Disease","Dacarbazine [DR:D00288]
 Vemurafenib [DR:D09996] (BRAF mutation positive)
 Dabrafenib mesylate [DR:D10104] (BRAF mutation positive)
 Encorafenib [DR:D11053] (BRAF mutation positive)
 Trametinib dimethyl sulfoxide [DR:D10176] (BRAF mutation positive)
 Cobimetinib fumarate [DR:D10615] (BRAF mutation positive)
 Binimetinib [DR:D10604] (BRAF mutation positive)
 Ipilimumab [DR:D04603]
 Nivolumab [DR:D10316]
 Pembrolizumab [DR:D10574]
 Talimogene laherparepvec [DR:D09966]
 Interferon alfa-2b [DR:D02745]
 Peginterferon alfa-2b [DR:D02748]
 Aldesleukin [DR:D00748]","ICD-O: 8720/3, Tumor type: Malignant melanoma","Disease","KEGG","Disease-Disease Interaction",16822996
"Basal cell carcinoma","Disease","Fluorouracil [DR:D00584]
 Cemiplimab [DR:D11108]
 Vismodegib [DR:D09992]
 Sonidegib phosphate [DR:D10729]","ICD-O: 8090/3, Tumor type: Basal cell carcinoma","Disease","KEGG","Disease-Disease Interaction",15978322
"Squamous cell carcinoma","Disease","Bleomycin sulfate [DR:D02177]
 Cemiplimab [DR:D11108]","ICD-O: 8070/3, Tumor type: squamous cell carcinoma","Disease","KEGG","Disease-Disease Interaction",15468170
"Kaposi sarcoma","Disease","Alitretinoin [DR:D02815]
 Vinblastine sulfate [DR:D01068]
 Paclitaxel [DR:D00491]
 Doxorubicin hydrochloride [DR:D01275]
 Interferon alfa-2b [DR:D02745]","ICD-O: 9140/3, Tumor type: Kaposi sarcoma","Disease","KEGG","Disease-Disease Interaction",11423257
"Glioma","Disease","Carmustine [DR:D00254]
 Temozolomide [DR:D06067]
 Bevacizumab [DR:D06409]
 Aminolevulinic acid hydrochloride [DR:D02908]","ICD-O: 9401/3, Tumor type: Anaplastic astrocytoma
 ICD-O: 9440/3, Tumor type: Glioblastoma","Disease","KEGG","Disease-Disease Interaction",15639402
"Neuroblastoma","Disease","Cyclophosphamide [DR:D00287]
 Vincristine sulfate [DR:D02197]
 Doxorubicin hydrochloride [DR:D01275]
 Naxitamab [DR:D11416]","ICD-O: 9500/3, Tumor type: Neuroblastoma","Disease","KEGG","Disease-Disease Interaction",12612655
"Cancer of the anal canal","Disease","Recombinant adsorbed quadrivalent human papillomavirus virus-like particle vaccine [DR:D10192]","ICD-O: 8070/3, Tumor type: Squamous cell carcinoma","Disease","KEGG","Disease-Disease Interaction",16607677
"Pancreatic neuroendocrine tumor","Disease","Lanreotide acetate [DR:D04666]
 Streptozocin [DR:D05932]
 Everolimus [DR:D02714]
 Sunitinib malate [DR:D06402]
 Lutetium (177Lu) oxodotreotide [DR:D11033] (somatostatin receptor-positive)","ICD-O-3: 8151/3 Insulinoma, malignant (C25._)
 ICD-O-3: 8153/3 Gastrinoma, malignant
 ICD-O-3: 8155/3 Vipoma, malignant
 ICD-O-3: 8152/3 Glucagonoma, malignant (C25._)
 ICD-O-3: 8156/3 Somatostatinoma, malignant","Disease","KEGG","Disease-Disease Interaction",27021395
"Cholangiocarcinoma","Disease","Pemigatinib [DR:D11417] (FGFR2 fusion positive)
 Infigratinib phosphate [DR:D11611] (FGFR2 fusion or other rearrangement)","ICD-O: 8160/3, Tumor type: Intrahepatic cholangiocarcinoma","Disease","KEGG","Disease-Disease Interaction",15218306
"Hepatocellular carcinoma;
 Liver cancer","Disease","Sorafenib tosylate [DR:D06272]
 Regorafenib hydrate [DR:D10137]
 Cabozantinib s-malate [DR:D10095]
 Lenvatinib mesylate [DR:D09920]
 Bevacizumab [DR:D06409]
 Ipilimumab [DR:D04603]
 Nivolumab [DR:D10316]
 Pembrolizumab [DR:D10574]
 Ramucirumab [DR:D09371]
 Atezolizumab [DR:D10773]","ICD-O: 8170/3, Tumor type: Hepatocellular carcinoma (liver cell carcinoma)","Disease","KEGG","Disease-Disease Interaction",21829020
"Alzheimer disease;
 Dementia due to Alzheimer disease","Disease","Donepezil hydrochloride [DR:D00670]
 Rivastigmine [DR:D03822]
 Rivastigmine tartrate [DR:D02558]
 Galantamine hydrobromide [DR:D02173]
 Memantine hydrochloride [DR:D04905]
 Aducanumab [DR:D10541]
 Memantine and donepezil [DR:D11387]","Disease class: tauopathy
 Affected region: hippocampus, cerebral cortex
 Microscopic lesion: amyloid plaques, neurofibrillary tangles, Lewy bodies (seen in Lewy body variant)","Disease","KEGG","Disease-Disease Interaction",19679070
"Parkinson disease","Disease","Droxidopa [DR:D01277]
 Bromocriptine mesylate [DR:D00780]
 Apomorphine hydrochloride [DR:D02004]
 Levodopa [DR:D00059]
 Carbidopa hydrate and levodopa [DR:D00253]
 Carbidopa, levodopa and entacapone [DR:D10293]
 Amantadine hydrochloride [DR:D00777]
 Ropinirole hydrochloride [DR:D00784]
 Pramipexole dihydrochloride [DR:D00559]
 Rotigotine [DR:D05768]
 Selegiline hydrochloride [DR:D00785]
 Rasagiline mesylate [DR:D02562]
 Safinamide mesylate [DR:D10191]
 Tolcapone [DR:D00786]
 Entacapone [DR:D00781]
 Opicapone [DR:D10825]
 Istradefylline [DR:D04641]
 Pimavanserin tartrate [DR:D08969]
 Carbidopa [DR:D00558]","Disease class: synucleinopathy
 Affected region: substantia nigra, putamen, caudate nucleus, hypothalamus
 Microscopic lesion: Lewy bodies","Disease","KEGG","Disease-Disease Interaction",19729209
"Amyotrophic lateral sclerosis (ALS);
 Lou Gehrig disease","Disease","Riluzole [DR:D00775]
 Edaravone [DR:D01552]","Affected region: motor cortex, brain stem, spinal cord
 Microscopic lesion: hyaline inclusions","Disease","KEGG","Disease-Disease Interaction",30870681
"Huntington disease","Disease","Tetrabenazine [DR:D08575]
 Deutetrabenazine [DR:D10701]","Disease class: polyglutamine disease
 Affected region: caudate nucleus, globus pallidus, thalamus, hippocampus
 Microscopic lesion: neuronal intranuclear inclusions","Disease","KEGG","Disease-Disease Interaction",18466116
"Asthma","Disease","Triamcinolone acetonide [DR:D00983]
 Dexamethasone [DR:D00292]
 Dexamethasone sodium phosphate [DR:D00975]
 Hydrocortisone [DR:D00088]
 Hydrocortisone sodium succinate [DR:D00978]
 Prednisolone [DR:D00472]
 Prednisolone sodium phosphate [DR:D00981]
 Prednisone [DR:D00473]
 Budesonide [DR:D00246]
 Beclomethasone dipropionate [DR:D00689]
 Methylprednisolone [DR:D00407]
 Methylprednisolone sodium succinate [DR:D00751]
 Methylprednisolone acetate [DR:D00979]
 Mometasone furoate [DR:D00690]
 Fluticasone propionate [DR:D01708]
 Fluticasone furoate [DR:D06315]
 Dupilumab [DR:D10354]
 Cortisone acetate [DR:D00973]
 Flunisolide [DR:D00324]
 Ciclesonide [DR:D01703]
 Salmeterol xinafoate and fluticasone propionate [DR:D08699]
 Metaproterenol sulfate [DR:D00685]
 Terbutaline sulfate [DR:D00688]
 Salmeterol xinafoate [DR:D00687]
 Formoterol fumarate [DR:D01373]
 Budesonide and formoterol fumarate dihydrate [DR:D09595]
 Mometasone furoate and formoterol fumarate [DR:D10295]
 Fluticasone furoate and vilanterol trifenatate [DR:D10501]
 Tiotropium bromide hydrate [DR:D01929]
 Theophylline [DR:D00371]
 Aminophylline hydrate [DR:D05429]
 Aminophylline dihydrate [DR:D11630]
 Theophylline and dextrose [DR:D10297]
 Zafirlukast [DR:D00411]
 Montelukast sodium [DR:D00529]
 Omalizumab [DR:D05251]
 Reslizumab [DR:D08985]
 Mepolizumab [DR:D04923]
 Benralizumab [DR:D09874]
 Zileuton [DR:D00414]","Allergen:
 Furred pet (cat, dog)
 Dust mite
 Cockroach
 Rodent (rat, mouse)
 Mold
 Pollen (tree, grass, weed)","Disease","KEGG","Disease-Disease Interaction",18446588
"Systemic lupus erythematosus","Disease","Triamcinolone acetonide [DR:D00983]
 Dexamethasone [DR:D00292]
 Dexamethasone sodium phosphate [DR:D00975]
 Hydrocortisone [DR:D00088]
 Hydrocortisone sodium succinate [DR:D00978]
 Prednisolone [DR:D00472]
 Prednisolone sodium phosphate [DR:D00981]
 Prednisone [DR:D00473]
 Methylprednisolone [DR:D00407]
 Methylprednisolone sodium succinate [DR:D00751]
 Methylprednisolone acetate [DR:D00979]
 Corticotropin [DR:D00146]
 Cortisone acetate [DR:D00973]
 Belimumab [DR:D03068]
 Hydroxychloroquine sulfate [DR:D02114]
 Anifrolumab [DR:D11082]","Autoantigen:
 Double-stranded DNA [CPD:C00434]
 H2A [HSA:474382]
 H2B [HSA:8346]
 H3 [HSA:3020]
 H4 [HSA:8359]
 Ro/SS-A [HSA:6737]
 La/SS-B [HSA:6741]
 Sm-B [HSA:6628]
 Sm-D [HSA:6632]
 NR2A [HSA:2903]
 NR2B [HSA:2904]
 Phosphatidyl-serine [CPD:C02737]
 C1q [HSA:712]","Disease","KEGG","Disease-Disease Interaction",12835292
"Hashimoto thyroiditis","Disease","Levothyroxine sodium [DR:D01010]
 Thyroid [DR:D06482] (Hashimoto's)","Autoantigens:
 Thyroidperoxidase (TPO) [HSA:7173]
 Thyroglobulin (Tg) [HSA:7038]
 Na+/ I- symporter (NIS) [HSA:6528]","Disease","KEGG","Disease-Disease Interaction",11913070
"Graves disease","Disease","Propylthiouracil [DR:D00562]
 Methimazole [DR:D00401]","Autoantigen: TSH-R [HSA:7253]","Disease","KEGG","Disease-Disease Interaction",15049952
"Chronic granulomatous disease","Disease","Interferon gamma-1b [DR:D00747]","X-linked CGD (gp91 phox CGD)
 p22phox deficiency (p22phox CGD)
 p47phox deficiency (p47phox CGD)
 p67phox deficiency (p67phox CGD)","Disease","KEGG","Disease-Disease Interaction",17162365
"Mucopolysaccharidosis type IV","Disease","Elosulfase alfa [DR:D10333]","Morquio syndrome B is allelic to the various forms of GM1-gangliosidosis (see, H00281). The latter disorders show central nervous system involvement.","Disease","KEGG","Disease-Disease Interaction",18708002
"Gaucher disease","Disease","Imiglucerase [DR:D03020]
 Velaglucerase alfa [DR:D09029]
 Taliglucerase alfa [DR:D09675]
 Miglustat [DR:D05032]
 Eliglustat tartrate [DR:D09894]","The most common mutations: N370S, L444P, 84GG, IVS2+1G>A, V394L, del55bp, D409H, R496H, and RecNciI.","Disease","KEGG","Disease-Disease Interaction",18708002
"Mucopolysaccharidosis type VII;
 Sly syndrome","Disease","Vestronidase alfa [DR:D11004]","Hematopoietic stem cell transplantation (limited experience)","Disease","KEGG","Disease-Disease Interaction",16601332
"Crohn disease","Disease","Prednisolone sodium phosphate [DR:D00981]
 Prednisone [DR:D00473]
 Budesonide [DR:D00246]
 Natalizumab [DR:D06886]
 Vedolizumab [DR:D08083]
 Infliximab [DR:D02598]
 Adalimumab [DR:D02597]
 Certolizumab pegol [DR:D03441]
 Ustekinumab [DR:D09214]","The polymorphysm in the TNFSF15 gene contribute to the susceptibility to Crohn's disease in the Japanese.","Disease","KEGG","Disease-Disease Interaction",11385577
"Familial Mediterranean fever;
 Familial hereditary periodic fever syndromes","Disease","Canakinumab [DR:D09315]
 Colchicine [DR:D00570]","{Alpha}/{alpha} genotype of SAA1 [HSA:6288] is a risk factor for amyloidosis.","Disease","KEGG","Disease-Disease Interaction",19339884
"Plague","Disease","Tetracycline hydrochloride [DR:D02122]
 Doxycycline [DR:D00307]
 Doxycycline hyclate [DR:D02129]
 Doxycycline calcium [DR:D03903]
 Minocycline hydrochloride [DR:D00850]
 Streptomycin sulfate [DR:D01350]
 Demeclocycline hydrochloride [DR:D00290]
 Ciprofloxacin [DR:D00186]
 Ciprofloxacin hydrochloride [DR:D02216]
 Levofloxacin [DR:D00588]
 Moxifloxacin hydrochloride [DR:D00874]","Vector: Xenopsylla cheopis (rat flea)
 murine toxin [KO:K11009]","Disease","KEGG","Disease-Disease Interaction",NA
"Chancroid","Disease","Tetracycline hydrochloride [DR:D02122]
 Doxycycline [DR:D00307]
 Doxycycline hyclate [DR:D02129]
 Doxycycline calcium [DR:D03903]
 Minocycline hydrochloride [DR:D00850]
 Streptomycin sulfate [DR:D01350]
 Demeclocycline hydrochloride [DR:D00290]
 Sulfadiazine [DR:D00587]","Pregnant women should be treated with either erythromycin or ceftriaxone regimens.","Disease","KEGG","Disease-Disease Interaction",12576620
"Pasteurellosis","Disease","Penicillin G potassium [DR:D01053]
 Penicillin G sodium [DR:D05408]","Pasteurella are usually not susceptible to dicloxacillin, cephalexin, clindamycin, or erythromycin.
 Potential virulence factors include capsular lipopolysaccharide, a cytotoxin, and iron acquisition proteins.","Disease","KEGG","Disease-Disease Interaction",6371440
"Q fever","Disease","Tetracycline hydrochloride [DR:D02122]
 Doxycycline [DR:D00307]
 Doxycycline hyclate [DR:D02129]
 Doxycycline calcium [DR:D03903]
 Minocycline hydrochloride [DR:D00850]
 Demeclocycline hydrochloride [DR:D00290]","Vector: Rhipicephalus sanguineus (brown dog tick)","Disease","KEGG","Disease-Disease Interaction",22125041
"Tularemia","Disease","Tetracycline hydrochloride [DR:D02122]
 Doxycycline [DR:D00307]
 Doxycycline hyclate [DR:D02129]
 Doxycycline calcium [DR:D03903]
 Minocycline hydrochloride [DR:D00850]
 Streptomycin sulfate [DR:D01350]
 Demeclocycline hydrochloride [DR:D00290]","Vector: Dermacentor reticulatus and Ixodes ricinus (tick)","Disease","KEGG","Disease-Disease Interaction",19713053
"Meningococcal infection","Disease","Penicillin G potassium [DR:D01053]
 Sulfadiazine [DR:D00587]","Antibiotic resistance in N. meningitidis ash been reported.","Disease","KEGG","Disease-Disease Interaction",19287450
"Campylobacter infection;
 Campylobacteriosis","Disease","Tetracycline hydrochloride [DR:D02122]
 Doxycycline [DR:D00307]
 Doxycycline hyclate [DR:D02129]
 Doxycycline calcium [DR:D03903]
 Minocycline hydrochloride [DR:D00850]
 Demeclocycline hydrochloride [DR:D00290]","Reservoirs: wild birds","Disease","KEGG","Disease-Disease Interaction",10081669
"Epidemic typhus","Disease","Tetracycline hydrochloride [DR:D02122]
 Doxycycline [DR:D00307]
 Doxycycline hyclate [DR:D02129]
 Doxycycline calcium [DR:D03903]
 Minocycline hydrochloride [DR:D00850]
 Demeclocycline hydrochloride [DR:D00290]","Vectors: Prediculus humanus (human body louse); Xenopsylla cheopis (rat flea) and Polyplax spinulos (rat louse)","Disease","KEGG","Disease-Disease Interaction",15353963
"Spotted fever;
 Tick-borne rickettsioses","Disease","Tetracycline hydrochloride [DR:D02122]
 Doxycycline [DR:D00307]
 Doxycycline hyclate [DR:D02129]
 Doxycycline calcium [DR:D03903]
 Minocycline hydrochloride [DR:D00850]
 Demeclocycline hydrochloride [DR:D00290]","Vectors: Rhipicephalus sanguineus (brown dog tick) for Rickettsia conorii","Disease","KEGG","Disease-Disease Interaction",16223955
"Bartonellosis","Disease","Tetracycline hydrochloride [DR:D02122]
 Doxycycline [DR:D00307]
 Doxycycline hyclate [DR:D02129]
 Doxycycline calcium [DR:D03903]
 Minocycline hydrochloride [DR:D00850]
 Demeclocycline hydrochloride [DR:D00290]","For trench fever, see also H00327.","Disease","KEGG","Disease-Disease Interaction",11176245
"Lyme borreliosis;
 Lyme disease","Disease","Doxycycline hyclate [DR:D02129]
 Cefuroxime axetil [DR:D00914]","Vector: Ixodes sp. (tick)","Disease","KEGG","Disease-Disease Interaction",21903253
"Cryptosporidiosis","Disease","Nitazoxanide [DR:D02486]","The most important therapy is hydroelectrolytic resuscitation. Antiretroviral therapy appears to play a critical role in resolution of AIDS-associated cryptosporidiosis.","Disease","KEGG","Disease-Disease Interaction",20521158
"African trypanosomiasis;
 Sleeping sickness","Disease","Fexinidazole [DR:D11252]","Vector: Glossina pallidipes (tsetse fly)","Disease","KEGG","Disease-Disease Interaction",19707588
"Chagas disease;
 American trypanosomiasis","Disease","Nifurtimox [DR:D00833]","Vector: Rhodnius prolixus (Reduviid bug)","Disease","KEGG","Disease-Disease Interaction",26222561
"Leishmaniasis","Disease","Amphotericin B [DR:D00203]
 Miltefosine [DR:D02494]","Vector: Phlebotomus papatasi (sand fly)","Disease","KEGG","Disease-Disease Interaction",28649370
"Malaria","Disease","Doxycycline hyclate [DR:D02129]
 Doxycycline calcium [DR:D03903]
 Sulfadiazine [DR:D00587]
 Chloroquine phosphate [DR:D02125]
 Hydroxychloroquine sulfate [DR:D02114]
 Primaquine phosphate [DR:D02126]
 Tafenoquine succinate [DR:D10670]
 Atovaquone and proguanil hydrochloride [DR:D02472]
 Quinine sulfate [DR:D02262]
 Mefloquine hydrochloride [DR:D00831]
 Pyrimethamine [DR:D00488]
 Artesunate [DR:D02482]
 Artemether and lumefantrine [DR:D02484]","Vector: Anopheles gambiae (African malaria mosquito) [GN:aga]","Disease","KEGG","Disease-Disease Interaction",23088834
"Rabies","Disease","Rabies vaccine [DR:D06504]","Preexposure vaccination with modern cell culture vaccine is recommended for people at high risk of exposure. Postexposure prophylaxis consists of wound cleansing and immunization with modern cell culture vaccine, together with administration of rabies immune globulin. There is no certain cure for rabies except supportive care.","Disease","KEGG","Disease-Disease Interaction",22348291
"Relapsing fever","Disease","Tetracycline hydrochloride [DR:D02122]
 Doxycycline [DR:D00307]
 Doxycycline hyclate [DR:D02129]
 Doxycycline calcium [DR:D03903]
 Minocycline hydrochloride [DR:D00850]
 Demeclocycline hydrochloride [DR:D00290]","Vectors: Pediculus humanus (body louse), Ornithodoros moubata (African tick)","Disease","KEGG","Disease-Disease Interaction",19886891
"Toxoplasmosis","Disease","Sulfadiazine [DR:D00587]
 Pyrimethamine [DR:D00488]","Definitive host: Felis silvestris catus","Disease","KEGG","Disease-Disease Interaction",30394261
"Osteopetrosis","Disease","Interferon gamma-1b [DR:D00747]","OBTB1, OPTB4, OBTP5, and OBTP8 are infantile malignant osteopetrosis.
 OPTB3 is osteopetrosis associated with renal tubular acidosis.","Disease","KEGG","Disease-Disease Interaction",20855225
"Spinal muscular atrophy","Disease","Nusinersen sodium [DR:D10791]
 Onasemnogene abeparvovec [DR:D11559] (bi-allelic SMN1 mutations)
 Risdiplam [DR:D11406]","About SMAX1, please refer to H00062, for detail.
 See also H00856 Distal hereditary motor neuropathies (dHMN).","Disease","KEGG","Disease-Disease Interaction",20302191
"Primary open angle glaucoma;
 Glaucoma 1","Disease","Timolol [DR:D00378]
 Timolol maleate [DR:D00603]
 Carteolol hydrochloride [DR:D00599]
 Betaxolol hydrochloride [DR:D00598]
 Brimonidine tartrate [DR:D02076]
 Mitomycin [DR:D00208]
 Pilocarpine hydrochloride [DR:D02200]
 Echothiophate iodide [DR:D02193]
 Acetazolamide [DR:D00218]
 Acetazolamide sodium [DR:D01196]
 Dorzolamide hydrochloride [DR:D00653]
 Brinzolamide [DR:D00652]
 Methazolamide [DR:D00655]
 Brinzolamide and brimonidine tartrate [DR:D10854]
 Levobunolol hydrochloride [DR:D01025]
 Metipranolol [DR:D02374]
 Dorzolamide hydrochloride and timolol maleate [DR:D08493]
 Brimonidine tartrate and timolol maleate [DR:D10298]
 Latanoprost [DR:D00356]
 Isopropyl unoprostone [DR:D01452]
 Bimatoprost [DR:D02724]
 Travoprost [DR:D01964]
 Tafluprost [DR:D06274]
 Latanoprostene bunod [DR:D10441]
 Netarsudil and latanoprost [DR:D11558]
 Netarsudil mesylate [DR:D11031]","GLC1G is a ribosome biogenesis disorder.","Disease","KEGG","Disease-Disease Interaction",21655191
"Premature ovarian failure","Disease","Estradiol [DR:D00105]","For galactosemia, see H00070.","Disease","KEGG","Disease-Disease Interaction",16722528
"Hyperkalemic periodic paralysis (HyperPP)","Disease","Dichlorphenamide [DR:D00518]","The T704M and M1592V mutations in the SCN4A gene account for the majority of cases.","Disease","KEGG","Disease-Disease Interaction",20634695
"Keratoconus","Disease","Riboflavin 5'-phosphate sodium [DR:D05725]","Keratoconus can also be found in sydromic conditions such as Down syndrome, mitral valve prolapse [DS:H00661], Marfan syndrome [DS:H00653], and Ehlers-Danlos syndrome [DS:H00802].","Disease","KEGG","Disease-Disease Interaction",11778802
"Idiopathic generalized epilepsies","Disease","Levetiracetam [DR:D00709]","The International League Against Epilepsy (ILAE) Commission on Classification and Terminology has revised concepts, terminology, and approaches for classifying seizures and forms of epilepsy. Genetic, structural-metabolic, and unknown represent modified concepts to replace idiopathic, symptomatic, and cryptogenic.","Disease","KEGG","Disease-Disease Interaction",15101828
"Age-related macular degeneration","Disease","Aflibercept [DR:D09574]
 Verteporfin [DR:D01162]
 Pegaptanib sodium [DR:D05386]
 Ranibizumab [DR:D05697]
 Brolucizumab [DR:D11083]","A haplotype carrying deletion of the complement factor H-related genes CFHR1 and CFHR3 is also associated with reduced risk of ARMD.","Disease","KEGG","Disease-Disease Interaction",18097986
"Onchocerciasis;
 River blindness;
 Robles disease","Disease","Ivermectin [DR:D00804]
 Moxidectin [DR:D05084]","Vector: Simulium blackflies","Disease","KEGG","Disease-Disease Interaction",20739055
"Cysticercosis","Disease","Albendazole [DR:D00134]","Intermediate host: Pig","Disease","KEGG","Disease-Disease Interaction",21788891
"Liver fluke disease;
 Fascioliasis","Disease","Triclabendazole [DR:D07364]","Intermediate host: freshwater snail species of the family Lymnaeidae","Disease","KEGG","Disease-Disease Interaction",18725803
"Pediculosis","Disease","Ivermectin [DR:D00804]
 Lindane [DR:D00360]
 Malathion [DR:D00534]
 Benzyl alcohol [DR:D00077]
 Spinosad [DR:D09384]
 Abametapir [DR:D10687]","Dichlorodiphenyltrichloroethane (DDT) [CPD:C04623] powder was the treatment of choice during World War II, but the lice began to show resistance to this pesticide during the 1950s.","Disease","KEGG","Disease-Disease Interaction",14699358
"Staphylococcal infection","Disease","Vancomycin hydrochloride [DR:D00926]
 Bacitracin [DR:D00128]
 Clindamycin palmitate hydrochloride [DR:D01990]
 Clindamycin hydrochloride [DR:D02132]","Treatment was most commonly initiated with vancomycin and narrowed as antibiotic susceptibilities allowed.
 Methicillin resistance has been reported.","Disease","KEGG","Disease-Disease Interaction",21886051
"Familial hyperinsulinemic hypoglycemia","Disease","Diazoxide [DR:D00294]","Leucine-induced hypoglycemia (LIH)","Disease","KEGG","Disease-Disease Interaction",16357843
"Yaws","Disease","Tetracycline hydrochloride [DR:D02122]
 Doxycycline [DR:D00307]
 Doxycycline hyclate [DR:D02129]
 Doxycycline calcium [DR:D03903]
 Minocycline hydrochloride [DR:D00850]
 Demeclocycline hydrochloride [DR:D00290]
 Penicillin G benzathine [DR:D02157]
 Penicillin G procaine [DR:D02461]","See also H01530 Pinta and H01531 Bejel.","Disease","KEGG","Disease-Disease Interaction",10330597
"Hyperprolactinemia","Disease","Bromocriptine mesylate [DR:D00780]
 Cabergoline [DR:D00987]","See also H01607.","Disease","KEGG","Disease-Disease Interaction",24195502
"Anaerobic infection","Disease","Metronidazole [DR:D00409]","Infectious disease caused by Bacteroides spp., Prevotella spp., Porphyromonas spp., Porphyromonas spp., Fusobacterium spp., Peptostreptococcus spp., Clostridium spp., Bilophila spp. and Actinomyces spp..","Disease","KEGG","Disease-Disease Interaction",16887500
"Obsessive-compulsive disorder","Disease","Clomipramine hydrochloride [DR:D00811]
 Fluoxetine hydrochloride [DR:D00823]
 Paroxetine hydrochloride [DR:D05374]
 Paroxetine mesylate [DR:D05375]
 Sertraline hydrochloride [DR:D00825]
 Fluvoxamine maleate [DR:D00824]","For Tourette syndrome, see H00862.","Disease","KEGG","Disease-Disease Interaction",21820387
"Diabetic neuropathy","Disease","Becaplermin [DR:D03065]
 Tapentadol hydrochloride [DR:D10199] (DPN)
 Pregabalin [DR:D02716]
 Duloxetine hydrochloride [DR:D01179]","Pregabalin [DR:D02716] (US and EU approved)","Disease","KEGG","Disease-Disease Interaction",16932298
"Mycosis fungoides","Disease","Triamcinolone acetonide [DR:D00983]
 Dexamethasone [DR:D00292]
 Dexamethasone sodium phosphate [DR:D00975]
 Hydrocortisone [DR:D00088]
 Hydrocortisone sodium succinate [DR:D00978]
 Prednisolone [DR:D00472]
 Prednisolone sodium phosphate [DR:D00981]
 Prednisone [DR:D00473]
 Methylprednisolone [DR:D00407]
 Methylprednisolone sodium succinate [DR:D00751]
 Methylprednisolone acetate [DR:D00979]
 Cortisone acetate [DR:D00973]
 Cyclophosphamide [DR:D00287]
 Mechlorethamine hydrochloride [DR:D04872]
 Methotrexate sodium [DR:D02115]
 Vinblastine sulfate [DR:D01068]
 Brentuximab vedotin [DR:D09587] (CD30 expressing)
 Mogamulizumab [DR:D09761] (CCR4-directed)
 Bexarotene [DR:D03106]
 Vorinostat [DR:D06320]
 Romidepsin [DR:D06637]
 Denileukin diftitox [DR:D03682] (CD25 express)","ICD-O-3.1: 9700/3 Mycosis fungoides","Disease","KEGG","Disease-Disease Interaction",18342689
"Mantle cell lymphoma","Disease","Ibrutinib [DR:D10223]
 Acalabrutinib [DR:D10893]
 Zanubrutinib [DR:D11422]
 Bortezomib [DR:D03150]
 Lenalidomide [DR:D04687]
 Brexucabtagene autoleucel [DR:D11880]","ICD-O-3.1: 9673/3 Mantle cell lymphoma","Disease","KEGG","Disease-Disease Interaction",26103436
"Short bowel syndrome","Disease","Teduglutide [DR:D06053]","Congenital small bowel syndrome is described in H01477. [DS:H01477]","Disease","KEGG","Disease-Disease Interaction",24486858
"Giant cell tumor of bone","Disease","Denosumab [DR:D03684]","ICD-O-3.1: 9250/1 Giant cell tumor of bone, NOS
 ICD-O-3.1: 9250/3 Giant cell tumor of bone, malignant","Disease","KEGG","Disease-Disease Interaction",24718514
"Erythema nodosum leprosum","Disease","Thalidomide [DR:D00754]","See also H00344 Leprosy.","Disease","KEGG","Disease-Disease Interaction",16687695
"Lipodystrophy;
 Lipoatrophy","Disease","Metreleptin [DR:D05014]","Lipodystrophy can be classified to the following subtypes.
 Genetic forms: Congential generalized lipodystrophy (CGL), H00420 Familial partial lipodystrophy (FPL), H00665 Mandibuloacral dysplasia-associated lipodystrophy (MDAL)
 Acquired forms: H01474 Acquired generalized lipodystrophy (AGL), Acquired partial, HIV-associated lipodystrophy","Disease","KEGG","Disease-Disease Interaction",21865368
"Infantile hemangioma","Disease","Propranolol hydrochloride [DR:D00483]","ICD-O-3.1: 9131/0 Infantile hemangioma","Disease","KEGG","Disease-Disease Interaction",19190505
"Neuromyelitis optica;
 Devic disease","Disease","Eculizumab [DR:D03940] (AQP4 antibody positive)
 Inebilizumab [DR:D11757] (AQP4 antibody positive)
 Satralizumab [DR:D11079] (anti-AQP4 antibody positive)","See also H01490 Multiple sclerosis.","Disease","KEGG","Disease-Disease Interaction",26950113
"Lupus nephritis","Disease","Voclosporin [DR:D09033]","See also H00080 Systemic lupus erythematosus.
 Lupus nephritis is staged according to the classification revised by the International Society of Nephrology (ISN) and the Renal Pathology Society (RPS) in 2003.","Disease","KEGG","Disease-Disease Interaction",14747370
"Hepatic encephalopathy;
 Hepatic coma","Disease","Rifaximin [DR:D02554]","Lactulose, probiotics, and extracorporeal albumin dialysis, especially MARS, have been demonstrated to be beneficial in cirrhotic patients.","Disease","KEGG","Disease-Disease Interaction",26557005
"Malignant paraganglioma","Disease","Iobenguane I 131 [DR:D03308]","ICD-O-3: 8700/3 Pheochromocytoma, malignant
 ICD-O-3: 8680/3 Paraganglioma, malignant
 ICD-O-3: 8693/3 Extra-adrenal paraganglioma, malignant","Disease","KEGG","Disease-Disease Interaction",25385035
"Mast-cell leukemia","Disease","Imatinib mesylate [DR:D01441]
 Midostaurin [DR:D05029]","ICD-O-3: 9742/3 Mast cell leukaemia","Disease","KEGG","Disease-Disease Interaction",23243287
"Langerhans cell histiocytosis","Disease","Vinblastine sulfate [DR:D01068]","ICD-O-3: 9752/1 Langerhans cell histiocytosis, unifocal
 ICD-O-3: 9753/1 Langerhans cell histiocytosis, multifocal
 ICD-O-3: 9754/3 Langerhans cell histiocytosis, disseminated","Disease","KEGG","Disease-Disease Interaction",26414464
"Retinoblastoma","Disease","Cyclophosphamide [DR:D00287]","ICD-O-3: 9510/3 Retinoblastoma, NOS
 ICD-O-3: 9511/3 Retinoblastoma, differentiated
 ICD-O-3: 9512/3 Retinoblastoma, undifferentiated
 ICD-O-3: 9513/3 Retinoblastoma, diffuse
 ICD-O-3: 9514/1 Retinoblastoma, spontaneously regressed","Disease","KEGG","Disease-Disease Interaction",26310174
"Pinta;
 Mal del pinto;
 Carate","Disease","Penicillin G benzathine [DR:D02157]
 Penicillin G procaine [DR:D02461]","See also H01318 Yaws and H01531 Bejel.","Disease","KEGG","Disease-Disease Interaction",10330597
"Bejel;
 Endemic syphilis","Disease","Penicillin G benzathine [DR:D02157]
 Penicillin G procaine [DR:D02461]","See also H01318 Yaws and H01530 Pinta.","Disease","KEGG","Disease-Disease Interaction",10330597
"HIV infection","Disease","Somatropin [DR:D02691]
 Saquinavir mesylate [DR:D01160]
 Indinavir sulfate [DR:D00897]
 Ritonavir [DR:D00427]
 Nelfinavir mesylate [DR:D00899]
 Fosamprenavir calcium [DR:D03835]
 Atazanavir sulfate [DR:D01276]
 Tipranavir [DR:D08605]
 Darunavir ethanolate [DR:D06478]
 Zidovudine [DR:D00413]
 Didanosine [DR:D00296]
 Stavudine [DR:D00445]
 Lamivudine [DR:D00353]
 Abacavir sulfate [DR:D00891]
 Tenofovir disoproxil fumarate [DR:D01982]
 Emtricitabine [DR:D01199]
 Nevirapine [DR:D00435]
 Delavirdine mesylate [DR:D00895]
 Efavirenz [DR:D00896]
 Etravirine [DR:D04112]
 Rilpivirine hydrochloride [DR:D09958]
 Doravirine [DR:D10624]
 Raltegravir potassium [DR:D07133]
 Elvitegravir [DR:D06677]
 Dolutegravir sodium [DR:D10113]
 Zidovudine and lamivudine [DR:D07507]
 Abacavir sulfate and lamivudine [DR:D08775]
 Emtricitabine and tenofovir disoproxil [DR:D02297]
 Abacavir, lamivudine and zidovudine [DR:D10838]
 Lamivudine, nevirapine and zidovudine [DR:D11521]
 Efavirenz, emtricitabine and tenofovir disoproxil [DR:D10851]
 Rilpivirine hydrochloride, tenofovir disoproxil fumarate and emtricitabine [DR:D10571]
 Elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil [DR:D10756]
 Lopinavir and ritonavir [DR:D02498]
 Efavirenz, lamivudine and tenofovir disoproxil fumarate [DR:D11392]
 Lamivudine and tenofovir disoproxil [DR:D11395]
 Dolutegravir, abacavir and lamivudine [DR:D10600]
 Darunavir and cobicistat [DR:D10832]
 Atazanavir and cobicistat [DR:D10753]
 Emtricitabine and tenofovir alafenamide [DR:D10835]
 Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide [DR:D10755]
 Emtricitabine, rilpivirine and tenofovir alafenamide [DR:D10836]
 Bictegravir, emtricitabine and tenofovir alafenamide [DR:D11039]
 Dolutegravir sodium and rilpivirine hydrochloride [DR:D11282]
 Darunavir, cobicistat, emtricitabine and tenofovir alafenamide [DR:D11382]
 Doravirine, lamivudine and tenofovir disoproxil [DR:D11396]
 Dolutegravir and lamivudine [DR:D11522]
 Enfuvirtide [DR:D02499]
 Maraviroc [DR:D06670] (CCR5-tropic)
 Ibalizumab [DR:D09575]
 Fostemsavir tromethamine [DR:D10708]
 Cobicistat [DR:D09881]
 Cabotegravir and rilpivirine [DR:D11966]","See also H00406 Acquired immunodeficiency syndrome (AIDS).","Disease","KEGG","Disease-Disease Interaction",21838892
"Acquired pure red cell aplasia","Disease","Triamcinolone acetonide [DR:D00983]
 Dexamethasone [DR:D00292]
 Hydrocortisone sodium succinate [DR:D00978]
 Prednisolone sodium phosphate [DR:D00981]
 Prednisone [DR:D00473]
 Methylprednisolone sodium succinate [DR:D00751]","See also H00237.","Disease","KEGG","Disease-Disease Interaction",18616874
"Systemic primary carnitine deficiency","Disease","Levocarnitine [DR:D02176]
 Levocarnitine chloride [DR:D02030]","See also H00525 Disorders of fatty-acid oxidation.","Disease","KEGG","Disease-Disease Interaction",23379544
"Chronic eosinophilic leukemia","Disease","Imatinib mesylate [DR:D01441] (FIP1L1-PDGFRA positive)","ICD-O-3:9964/3 Chronic eosinophilic leukemia, NOS","Disease","KEGG","Disease-Disease Interaction",15070659
"Gastrotintestinal stromal tumor","Disease","Imatinib mesylate [DR:D01441] (KIT positive)
 Sunitinib malate [DR:D06402]
 Regorafenib hydrate [DR:D10137]
 Avapritinib [DR:D11279] (PDGFRA mutaion positive)
 Ripretinib [DR:D11353]","ICD-O-3:8936/1 Gastrointestinal stromal tumor, NOS
 ICD-O-3:8936/3 Gastrointestinal stromal sarcoma","Disease","KEGG","Disease-Disease Interaction",25414046
"Medullary thyroid cancer","Disease","Vandetanib [DR:D06407]
 Cabozantinib s-malate [DR:D10095]
 Pralsetinib [DR:D11712] (RET mutant)
 Selpercatinib [DR:D11713] (RET mutant)","ICD-O-3:8345/3 Medullary carcinoma with amyloid stroma","Disease","KEGG","Disease-Disease Interaction",25972318
"Myasthenia gravis","Disease","Eculizumab [DR:D03940] (AchR antibody positive)
 Pyridostigmine bromide [DR:D00487]
 Edrophonium chloride [DR:D00994] (emergency treatment)","Autoantigen:
 CHRNA1 [HSA:1134] [KO:K04803]
 MUSK [HSA:4593] [KO:K05129]
 LRP4 [HSA:4038] [KO:K20051]","Disease","KEGG","Disease-Disease Interaction",24530233
"Cutaneous lupus erythematosus","Disease","Triamcinolone hexacetonide [DR:D00985]
 Methylprednisolone acetate [DR:D00979]
 Hydroxychloroquine sulfate [DR:D02114]","See also H00080 Systemic lupus erythematosus, and H00291 Familial chilblain lupus (FCL).","Disease","KEGG","Disease-Disease Interaction",27270345
"Lambert-Eaton myasthenic syndrome","Disease","Amifampridine [DR:D10228]
 Amifampridine phosphate [DR:D10689]
 Guanidine hydrochloride [DR:D11626]","Autoantigen:
 CACNB2 [HSA:783] [KO:K04863]","Disease","KEGG","Disease-Disease Interaction",25195700
"Hypereosinophilic syndrome","Disease","Imatinib mesylate [DR:D01441] (FIP1L1-PDGFRA positive)","ICD-O-3: 9964/3 Chronic eosinophilic leukemia, NOS","Disease","KEGG","Disease-Disease Interaction",26475367
"Anaplastic large-cell lymphoma","Disease","Crizotinib [DR:D09731] (ALK-positive)
 Brentuximab vedotin [DR:D09587]","ICD-O-3: 9718/3 Primary cutaneous CD30+ T-cell lymphoproliferative disorder (C44._)
 ICD-O-3: 9702/3 Mature T-cell lymphoma, NOS
 ICD-O-3: 9714/3 Anaplastic large cell lymphoma, T cell and Null cell type","Disease","KEGG","Disease-Disease Interaction",25869285
"Polymyositis and dermatomyositis","Disease","Triamcinolone acetonide [DR:D00983]
 Dexamethasone [DR:D00292]
 Hydrocortisone sodium succinate [DR:D00978]
 Prednisolone sodium phosphate [DR:D00981]
 Prednisone [DR:D00473]
 Methylprednisolone [DR:D00407]
 Methylprednisolone sodium succinate [DR:D00751]
 Methylprednisolone acetate [DR:D00979]
 Corticotropin [DR:D00146]
 Cortisone acetate [DR:D00973]","Autoantigen:
 HARS [HSA:3035] [KO:K01892]
 TARS [HSA:6897] [KO:K01868]
 AARS [HSA:16] [KO:K01872]
 GARS [HSA:2617] [KO:K01880]
 IARS [HSA:3376] [KO:K01870]
 NARS [HSA:4677] [KO:K01893]
 FARSA [HSA:2193] [KO:K01889]
 FARSB [HSA:10056] [KO:K01890]
 IFIH1 [HSA:64135] [KO:K12647]
 TRIM33 [HSA:51592] [KO:K08883]
 MORC3 [HSA:23515]
 SAE1 [HSA:10055] [KO:K10684]
 SAE2 [HSA:10054] [KO:K10685]","Disease","KEGG","Disease-Disease Interaction",26299472
"Myelofibrosis","Disease","Oxymetholone [DR:D00490]
 Ruxolitinib phosphate [DR:D09960]
 Fedratinib hydrochloride [DR:D11296]","ICD-0-3: 9961/3 Primary myelofibrosis","Disease","KEGG","Disease-Disease Interaction",25635755
"Clonorchiasis","Disease","Praziquantel [DR:D00471]","The first intermediate hosts: freshwater snails (predominantly of the genus Parafossarulus and Bithynia)
 The second intermediate hosts: freshwater fish (predominantly of the family Cyprinidae)","Disease","KEGG","Disease-Disease Interaction",16153321
"Follicular lymphoma","Disease","Chlorambucil [DR:D00266]
 Idelalisib [DR:D10560]
 Copanlisib hydrochloride hydrate [DR:D10798]
 Duvelisib hydrate [DR:D11658]
 Obinutuzumab [DR:D09321]
 Interferon alfa-2b [DR:D02745]
 Lenalidomide [DR:D04687]
 Ibritumomab tiuxetan [DR:D04489]
 Umbralisib tosylate [DR:D11323]
 Rituximab and hyaluronidase [DR:D11393]
 Tazemetostat hydrobromide [DR:D11485] (EZH2 mutation positive)
 Lisocabtagene maraleucel [DR:D11990]","ICD-O-3: 9690/3 Follicular lymphoma, NOS
 ICD-O-3: 9691/3 Follicular lymphoma, grade 2
 ICD-O-3: 9695/3 Follicular lymphoma, grade 1
 ICD-O-3: 9698/3 Follicular lymphoma, grade 3","Disease","KEGG","Disease-Disease Interaction",24687887
"Multiple system atrophy","Disease","Droxidopa [DR:D01277]","See also H01600 Parkinsonian syndrome.","Disease","KEGG","Disease-Disease Interaction",26785838
"Postherpetic neuralgia","Disease","Gabapentin [DR:D00332]
 Gabapentin enacarbil [DR:D09539]
 Pregabalin [DR:D02716]","See also H00366 Herpes zoster.","Disease","KEGG","Disease-Disease Interaction",26175877
"Opisthorchiasis","Disease","Praziquantel [DR:D00471]","The first intermediate hosts: prosobranch gastropod genus Bithynia
 The second intermediate hosts: freshwater fish, mostly cyprinoids","Disease","KEGG","Disease-Disease Interaction",24520562
"Chronic arterial occlusive disease","Disease","Pentoxifylline [DR:D00501]","See also H01625 Buerger's disease and H01626 Arteriosclerosis obliterans.","Disease","KEGG","Disease-Disease Interaction",14042045
"Peptic ulcer","Disease","Cimetidine [DR:D00295]
 Cimetidine hydrochloride [DR:D03503]
 Ranitidine hydrochloride [DR:D00673]
 Famotidine [DR:D00318]
 Nizatidine [DR:D00440]
 Misoprostol [DR:D00419]
 Omeprazole [DR:D00455]
 Omeprazole magnesium [DR:D05259]
 Lansoprazole [DR:D00355]
 Rabeprazole sodium [DR:D00724]
 Esomeprazole magnesium [DR:D01984]
 Esomeprazole sodium [DR:D04056]
 Esomeprazole strontium [DR:D10120]
 Esomeprazole magnesium dihydrate [DR:D11114]
 Sucralfate [DR:D00446]
 Glycopyrrolate [DR:D00540]
 Propantheline bromide [DR:D00481]
 Hyoscyamine sulfate [DR:D00719]
 Chlordiazepoxide hydrochloride and clidinium bromide [DR:D10247]
 Ibuprofen and famotidine [DR:D11575]
 Naproxen and esomeprazole magnesium [DR:D11576]
 Methscopolamine bromide [DR:D00715]
 Omeprazole and sodium bicarbonate [DR:D11706]","See also H00320 Helicobacter pylori infection.","Disease","KEGG","Disease-Disease Interaction",17956071
"Neuropathic pain;
 Neuralgia","Disease","Carbamazepine [DR:D00252]","See also H01459 Diabetic neuropathy and H01624 Postherpetic neuralgia.","Disease","KEGG","Disease-Disease Interaction",16880448
"Uterine leiomyoma;
 Fibroid","Disease","Leuprolide acetate [DR:D00989]
 Elagolix, estradiol and norethisterone [DR:D12137]","ICD-O-3: 8890/0 Leiomyoma, NOS","Disease","KEGG","Disease-Disease Interaction",NA
"Pemphigus","Disease","Triamcinolone acetonide [DR:D00983]
 Dexamethasone [DR:D00292]
 Dexamethasone sodium phosphate [DR:D00975]
 Hydrocortisone [DR:D00088]
 Hydrocortisone sodium succinate [DR:D00978]
 Prednisolone [DR:D00472]
 Prednisolone sodium phosphate [DR:D00981]
 Prednisone [DR:D00473]
 Methylprednisolone [DR:D00407]
 Methylprednisolone sodium succinate [DR:D00751]
 Methylprednisolone acetate [DR:D00979]
 Cortisone acetate [DR:D00973]
 Rituximab [DR:D02994]","Autoantigen:
 DSG1 [HSA:1828] [KO:K07596]
 DSG3 [HSA:1830] [KO:K07598]","Disease","KEGG","Disease-Disease Interaction",25078507
"Bipolar disorder;
 Manic depressive illness","Disease","Divalproex sodium [DR:D00304]
 Lamotrigine [DR:D00354]
 Chlorpromazine hydrochloride [DR:D00789]
 Ziprasidone hydrochloride [DR:D01939]
 Lurasidone hydrochloride [DR:D04820]
 Loxapine [DR:D02340]
 Olanzapine [DR:D00454]
 Quetiapine fumarate [DR:D00458]
 Asenapine maleate [DR:D02995]
 Lithium carbonate [DR:D00801]
 Risperidone [DR:D00426]
 Aripiprazole [DR:D01164]
 Aripiprazole hydrate [DR:D10516]
 Cariprazine hydrochloride [DR:D09876]
 Fluoxetine hydrochloride [DR:D00823]
 Olanzapine and fluoxetine hydrochloride [DR:D10206]
 Olanzapine and samidorphan [DR:D12117]","Bipolar I disorder: At least one manic episode must be presented, although major depressive episodes are typical but not needed for diagnosis.
 Bipolar II disorder: At least one hypomanic episode and one major depressive episode are needed for diagnosis.
 See also H01646 Major depressive disorder.","Disease","KEGG","Disease-Disease Interaction",26388529
"Primary peritoneal carcinoma","Disease","Bevacizumab [DR:D06409]
 Niraparib tosilate hydrate [DR:D11895]","ICD-O-3: 8461/3 Serous surface papillary carcinoma (C56.9)","Disease","KEGG","Disease-Disease Interaction",11014956
"Medulloblastoma","Disease","Carmustine [DR:D00254]","ICD-O-3: 9471/3 Desmoplastic nodular medulloblastoma","Disease","KEGG","Disease-Disease Interaction",18676356
"Juvenile idiopathic arthritis","Disease","Triamcinolone acetonide [DR:D00983]
 Dexamethasone [DR:D00292]
 Dexamethasone sodium phosphate [DR:D00975]
 Hydrocortisone [DR:D00088]
 Hydrocortisone sodium succinate [DR:D00978]
 Prednisolone [DR:D00472]
 Prednisolone sodium phosphate [DR:D00981]
 Prednisone [DR:D00473]
 Sulfasalazine [DR:D00448]
 Methylprednisolone [DR:D00407]
 Methylprednisolone sodium succinate [DR:D00751]
 Methylprednisolone acetate [DR:D00979]
 Naproxen [DR:D00118]
 Naproxen sodium [DR:D00970]
 Corticotropin [DR:D00146]
 Cortisone acetate [DR:D00973]
 Methotrexate [DR:D00142]
 Methotrexate sodium [DR:D02115]
 Celecoxib [DR:D00567]
 Abatacept [DR:D03203]
 Tofacitinib citrate [DR:D09783]
 Etanercept [DR:D00742]
 Adalimumab [DR:D02597]
 Tocilizumab [DR:D02596]
 Canakinumab [DR:D09315]
 Oxaprozin [DR:D00463]
 Naproxen and esomeprazole magnesium [DR:D11576]","See also H01516 Adult onset Still's disease.","Disease","KEGG","Disease-Disease Interaction",27461267
"Ankylosing spondylitis;
 Bechterew disease","Disease","Triamcinolone acetonide [DR:D00983]
 Dexamethasone [DR:D00292]
 Dexamethasone sodium phosphate [DR:D00975]
 Hydrocortisone [DR:D00088]
 Hydrocortisone sodium succinate [DR:D00978]
 Prednisolone [DR:D00472]
 Prednisolone sodium phosphate [DR:D00981]
 Prednisone [DR:D00473]
 Indomethacin [DR:D00141]
 Methylprednisolone [DR:D00407]
 Methylprednisolone sodium succinate [DR:D00751]
 Methylprednisolone acetate [DR:D00979]
 Naproxen [DR:D00118]
 Naproxen sodium [DR:D00970]
 Corticotropin [DR:D00146]
 Cortisone acetate [DR:D00973]
 Celecoxib [DR:D00567]
 Etanercept [DR:D00742]
 Infliximab [DR:D02598]
 Adalimumab [DR:D02597]
 Certolizumab pegol [DR:D03441]
 Golimumab [DR:D04358]
 Secukinumab [DR:D09967]
 Naproxen and esomeprazole magnesium [DR:D11576]
 Meclofenamate sodium [DR:D00169]","See also H00630 Rheumatoid arthritis and H01656 Psoriasis.","Disease","KEGG","Disease-Disease Interaction",23090374
"Chronic pancreatitis","Disease","Pancrelipase [DR:D05349]","See also H00933 Hereditary pancreatitis.","Disease","KEGG","Disease-Disease Interaction",20567557
"Renal angiomyolipoma","Disease","Everolimus [DR:D02714]","See also H00915 Tuberous sclerosis complex (TSC)","Disease","KEGG","Disease-Disease Interaction",26612197
"Subependymal giant cell astrocytoma","Disease","Everolimus [DR:D02714]","See also H00915 Tuberous sclerosis complex (TSC)","Disease","KEGG","Disease-Disease Interaction",22562196
"Stevens-Johnson syndrome;
 Toxic epidermal necrolysis;
 Lyell syndrome","Disease","Triamcinolone acetonide [DR:D00983]
 Dexamethasone [DR:D00292]
 Dexamethasone sodium phosphate [DR:D00975]
 Hydrocortisone [DR:D00088]
 Hydrocortisone sodium succinate [DR:D00978]
 Prednisolone [DR:D00472]
 Prednisolone sodium phosphate [DR:D00981]
 Prednisone [DR:D00473] (Stevens-Johnson syndrome)
 Methylprednisolone [DR:D00407]
 Methylprednisolone sodium succinate [DR:D00751]
 Methylprednisolone acetate [DR:D00979]
 Corticotropin [DR:D00146]
 Cortisone acetate [DR:D00973]","Two genetic risk variants, HLA-B1502 and HLA-A3101, for Carbamazepine-induced hypersensitivity reactions have been identified.","Disease","KEGG","Disease-Disease Interaction",27738400
"Erythema multiforme","Disease","Triamcinolone acetonide [DR:D00983]
 Dexamethasone [DR:D00292]
 Dexamethasone sodium phosphate [DR:D00975]
 Hydrocortisone [DR:D00088]
 Hydrocortisone sodium succinate [DR:D00978]
 Prednisolone [DR:D00472]
 Prednisolone sodium phosphate [DR:D00981]
 Methylprednisolone [DR:D00407]
 Methylprednisolone sodium succinate [DR:D00751]
 Corticotropin [DR:D00146]
 Cortisone acetate [DR:D00973]","See also H01694 Stevens-Johnson syndrome and Toxic epidermal necrolysis, H00365 Herpes simplex infection, and H00341 Mycoplasma pneumonia.","Disease","KEGG","Disease-Disease Interaction",23766045
"Giant cell arteritis;
 Temporal arteritis","Disease","Triamcinolone acetonide [DR:D00983]
 Dexamethasone [DR:D00292]
 Hydrocortisone sodium succinate [DR:D00978]
 Prednisolone sodium phosphate [DR:D00981]
 Methylprednisolone sodium succinate [DR:D00751]
 Methylprednisolone acetate [DR:D00979]
 Tocilizumab [DR:D02596]","See also H01465 Large-vessel vasculitis (LVV).","Disease","KEGG","Disease-Disease Interaction",27708947
"Isolated TSH deficiency","Disease","Paricalcitol [DR:D00930]","See also H00250 Congenital nongoitrous hypothyroidism (CHNG).","Disease","KEGG","Disease-Disease Interaction",15292359
"Glucocorticoid-induced osteonecrosis","Disease","Alendronate sodium [DR:D00939]
 Risedronate sodium [DR:D00942]
 Sodium risedronate hydrate [DR:D03234]
 Risedronate sodium monohydrate [DR:D11570]
 Zoledronic acid [DR:D01968]","See also H01529 Avascular necrosis of femoral head.","Disease","KEGG","Disease-Disease Interaction",21732837
"Chronic obstructive pulmonary disease (COPD);
 Emphysema","Disease","Glycopyrrolate [DR:D00540]
 Prednisolone sodium phosphate [DR:D00981]
 Prednisone [DR:D00473]
 Salmeterol xinafoate and fluticasone propionate [DR:D08699]
 Ipratropium bromide [DR:D02212]
 Metaproterenol sulfate [DR:D00685]
 Terbutaline sulfate [DR:D00688]
 Salmeterol xinafoate [DR:D00687]
 Formoterol fumarate [DR:D01373]
 Formoterol fumarate hydrate [DR:D05277]
 Indacaterol maleate [DR:D09319]
 Olodaterol hydrochloride [DR:D10020]
 Budesonide and formoterol fumarate dihydrate [DR:D09595]
 Fluticasone furoate and vilanterol trifenatate [DR:D10501]
 Albuterol sulfate and ipratropium bromide [DR:D10256]
 Umeclidinium bromide and vilanterol [DR:D10533]
 Glycopyrronium bromide and indacaterol maleate [DR:D10505]
 Tiotropium and olodaterol [DR:D10744]
 Glycopyrrolate and formoterol [DR:D11036]
 Fluticasone furoate, umeclidinium bromide and vilanterol [DR:D11035]
 Tiotropium bromide hydrate [DR:D01929]
 Aclidinium bromide [DR:D08837]
 Umeclidinium bromide [DR:D10181]
 Revefenacin [DR:D10978]
 Aminophylline hydrate [DR:D05429]
 Aminophylline dihydrate [DR:D11630]
 Theophylline and dextrose [DR:D10297]
 Roflumilast [DR:D05744]
 Acetylcysteine [DR:D00221]
 Arformoterol tartrate [DR:D02981]
 Aclidinium bromide and formoterol fumarate [DR:D11857]","See also H01103 Alpha-1-antitrypsin (A1AT) deficiency","Disease","KEGG","Disease-Disease Interaction",18046867
"Optic neuritis","Disease","Dexamethasone sodium phosphate [DR:D00975]
 Hydrocortisone [DR:D00088]
 Prednisolone [DR:D00472]
 Methylprednisolone [DR:D00407]
 Corticotropin [DR:D00146]
 Cortisone acetate [DR:D00973]","See also H01490 Multiple sclerosis and H01491 Neuromyelitis optica.","Disease","KEGG","Disease-Disease Interaction",22960967
"Pulmonary atresia with ventricular septal defect","Disease","Alprostadil [DR:D00180]","See also H01525 22q11.2 deletion syndrome, and H00549 Tetralogy of Fallot.","Disease","KEGG","Disease-Disease Interaction",28231853
"Dravet syndrome","Disease","Fenfluramine hydrochloride [DR:D04148]
 Stiripentol [DR:D05928]
 Cannabidiol [DR:D10915]","See also H00606 Early infantile epileptic encephalopathy.","Disease","KEGG","Disease-Disease Interaction",21463272
"Hypoparathyroidism","Disease","Calcitriol [DR:D00129]
 Parathyroid hormone (human) [DR:D05364]","See also H01524 DiGeorge syndrome, H01271 HDR syndrome, H00619 Kenny-Caffey syndrome, and H01355 Kearns-Sayre syndrome.","Disease","KEGG","Disease-Disease Interaction",15728199
"Obliterative bronchiolitis;
 Bronchiolitis obliterans","Disease","Prednisolone sodium phosphate [DR:D00981]","In the present manuscript, the following terminology is used: \bronchiolitis obliterans\ (historically used for the histopathological lesions) to name the pathological feature of reduced lumen of the bronchioles, and \obliterative bronchiolitis\ (OB) to name its functional counterpart with airflow obstruction.","Disease","KEGG","Disease-Disease Interaction",26335918
"Peripheral T cell lymphoma","Disease","Pralatrexate [DR:D05589]
 Brentuximab vedotin [DR:D09587] (CD30 expressing)
 Romidepsin [DR:D06637]
 Belinostat [DR:D08870]","9702/3 Mature T-cell lymphoma, NOS
 9705/3 Angioimmunoblastic T-cell lymphoma
 9714/3 Anaplastic large cell lymphoma, T cell and Null cell type","Disease","KEGG","Disease-Disease Interaction",28303495
"Barrett esophagus","Disease","Porfimer sodium [DR:D03327]","See also H01602 Gastroesophageal reflux disease (GERD) and H00017 Esophageal cancer.","Disease","KEGG","Disease-Disease Interaction",21461873
"Genetic obesity","Disease","Setmelanotide acetate [DR:D11928]","BMIQ is an abbreviation for BMI (body mass index) quantitative trait locus.","Disease","KEGG","Disease-Disease Interaction",15703762
"Nephroblastoma;
 Wilms tumor","Disease","Vincristine sulfate [DR:D02197]
 Dactinomycin [DR:D00214]
 Doxorubicin hydrochloride [DR:D01275]
 Dinutuximab [DR:D10559]","ICD-O-3.1: 8959/1 Cystic partially differentiated nephroblastoma
 ICD-O-3.1: 8960/3 Nephroblastoma","Disease","KEGG","Disease-Disease Interaction",27512769
"Vaccinia","Disease","Vaccinia immune globulin [DR:D06271]","After smallpox was declared eradicated, the vaccination was discontinued, favoring a new contingent of susceptible individuals to orthopoxviruses.","Disease","KEGG","Disease-Disease Interaction",12742570
"Scedosporiosis;
 Pseudoallescheriosis","Disease","Voriconazole [DR:D00578]","Eumycetoma [DS:H02385] is a chronic subcutaneous infection characterized by the production of grains, whereas scedosporiosis includes all other infections caused by Scedosporium apiospermum.","Disease","KEGG","Disease-Disease Interaction",18202441
"Myelodysplastic/myeloproliferative neoplasms","Disease","Imatinib mesylate [DR:D01441]","ICD-O: 9945/3 Chronic myelomonocytic leukemia
 ICD-O: 9876/3 Atypical chronic myelogenous leukemia
 ICD-O: 9946/3 Juvenile myelomonocytic leukemia","Disease","KEGG","Disease-Disease Interaction",28771058
"Phthiriasis;
 Phthiriasis pubis;
 Pubic lice infestation","Disease","Lindane [DR:D00360]","Dichlorodiphenyltrichloroethane (DDT) [CPD:C04623] powder was the treatment of choice during World War II, but the lice began to show resistance to this pesticide during the 1950s.","Disease","KEGG","Disease-Disease Interaction",14699358
"Diffuse large B-cell lymphoma, not otherwise specified","Disease","Tafasitamab [DR:D11601] (CD19-directed)
 Polatuzumab vedotin [DR:D10761]
 Loncastuximab tesirine [DR:D11338]
 Rituximab and hyaluronidase [DR:D11393]
 Lisocabtagene maraleucel [DR:D11990]","ICD-O-3: M9680/3 Malignant lymphoma, large cell, diffuse NOS","Disease","KEGG","Disease-Disease Interaction",29167021
